A fluorescence in situ hybridization-based screen allows rapid detection of adverse cytogenetic alterations in patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

A fluorescence in situ hybridization-based screen allows rapid detection of adverse cytogenetic alterations in patients with acute myeloid leukemia

Published:2017-05-19 Issue:8 Volume:56 Page:632-638
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Sandhöfer Nadine¹^ORCID,Metzeler Klaus H.¹,Kakadia Purvi M.²,Pasalic Zlatana¹,Hiddemann Wolfgang¹,Neusser Michaela³,Steinlein Ortrud³,Fiegl Michael¹,Subklewe Marion¹,Spiekermann Karsten¹,Bohlander Stefan K.²,Schneider Stephanie¹,Braess Jan⁴

Affiliation:

1. Department of Internal Medicine III; Laboratory for Leukemia Diagnostics, Ludwig-Maximilians-University; Munich Germany

2. Department of Molecular Medicine and Pathology; University of Auckland; New Zealand

3. Institute of Human Genetics, University Hospital, Ludwig-Maximilians-University; Munich Germany

4. Department of Oncology and Hematology; Hospital Barmherzige Brüder; Regensburg Germany

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference31 articles.

1. Cytogenetics in acute leukemia;Mrozek;Blood Rev.,2004

2. Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia;Mrozek;Hematology Am Soc Hematol Educ Program,2006

3. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Döhner;Blood,2010

4. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials;Grimwade;Blood,2010

5. Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup;Schlenk;J Clin Oncol,2004